Letter From the Editor: Liver Transplant in Patients With Obesity

It is well known that obesity is a significant public health issue both worldwide and in the United States. According to global estimates from the World […]

Letter From the Editor: Exploring the Utility of Potassium-Competitive Acid Blockers in Acid Peptic Disorders

Do potassium-competitive acid blockers have a role to play in the management of patients with acid peptic disorders? This question is explored in a review article […]

Letter From the Editor: Rapid Initiation of Hepatitis C Virus Treatment

We are currently fortunate to have safe and efficient therapy for the treatment of patients with hepatitis C virus (HCV) infection. In clinical practice, a frequently […]

Letter From the Editor: Emerging Treatments for Inflammatory Bowel Disease

Which therapies look promising as future therapeutic options for the treatment of patients with inflammatory bowel disease (IBD)? A review article in this month’s issue of […]

Letter From the Editor: Spotlight on COVID-19

Over the past several years, COVID-19 has had an enormous impact on our lives. This month’s issue of Gastroenterology & Hepatology features two timely and interesting […]

Managing Patients With Helicobacter pylori Infection

Helicobacter pylori infection affects more than one-half of the global population and almost one-third of the US population. Management of this infection has become more challenging […]

Letter From the Editor: Treatment for Patients With Inflammatory Bowel Disease

There has been a significant expansion in the options for inflammatory bowel disease (IBD) treatment over the past decade. A number of articles in this month’s […]

Exploring Pig-to-Human Liver Xenotransplantation

Every day, people die waiting for an organ transplant. Could using organs from pigs help reduce the shortage of organs? This month’s issue of Gastroenterology & […]

Letter From the Editor: COVID-19 Vaccines in Patients Who Have Inflammatory Bowel Disease

How safe and effective are COVID-19 vaccines in patients with inflammatory bowel disease (IBD)? This timely question is explored in a review article in this month’s […]

Letter From the Editor: Diagnosing and Managing Abdominal Bloating and Distension

It is well recognized that abdominal bloating and distension are common gastrointestinal symptoms. As Dr David J. Cangemi and Dr Brian E. Lacy note in a […]

Letter From the Editor: Screening for Depression in Patients Who Have Inflammatory Bowel Disease

Do all patients who have inflammatory bowel disease (IBD) need to be screened for depression, and when should any screening occur? These questions are explored in […]

Letter From the Editor: Liver Transplantation in Patients Who Have Hepatocellular Carcinoma

As of the beginning of August 2021, the United States was on track to perform more than 40,000 organ transplants in one year for the first […]

Letter From the Editor: Testing and Research Involving Hepatitis Delta Virus

Hepatitis delta virus (HDV) has been called the worst form of human viral hepatitis, as Dr Jeffrey S. Glenn notes in this month’s issue of Gastroenterology […]

Letter From the Editor: Dual Biologic Therapy in Patients Who Have Inflammatory Bowel Disease

Is dual biologic therapy safe and effective for the treatment of patients with inflammatory bowel disease? This question is explored in a review article in this […]

Letter From the Editor: Exploring Immune Checkpoint Inhibitor Colitis

The use of immune checkpoint inhibitors has been increasing. Although these agents can be effective treatment options for a number of malignancies, including melanoma and renal […]

Letter From the Editor: Refractory Gastroesophageal Reflux Disease

Suspected gastroesophageal reflux disease (GERD) is one of the most common reasons that a patient visits a primary care doctor or gastroenterologist. One of the review […]

Letter From the Editor: The Importance of Early Detection of Pancreatic Cancer

In the United States, pancreatic cancer is the fourth leading cause of cancer-related deaths and is expected to rise to the second leading cause by 2030. […]

Letter From the Editor: Managing Renal Dysfunction in Patients Who Have Cirrhosis

How should renal dysfunction be managed in patients who have cirrhosis? This question is explored in a review article in this month’s issue of Gastroenterology & […]

Letter From the Editor: Eating Disorders and Their Gastrointestinal and Oral Manifestations

It is estimated that approximately 9% of the US population will experience an eating disorder at some point during their lifetime. The yearly economic cost of […]

Letter From the Editor: Management of Patients Hospitalized for Acute Severe Ulcerative Colitis

How should we manage patients who require hospitalization for acute severe ulcerative colitis? This question is the focus of the Advances in IBD column in this […]